美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
NALBUPHINE HYDROCHLORIDE	074471	001	ANDA	NALBUPHINE HYDROCHLORIDE	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	100MG/10ML (10MG/ML)	No	No	1998/03/19	1998/03/19	DR REDDYS	Discontinued
NALBUPHINE HYDROCHLORIDE	074471	002	ANDA	NALBUPHINE HYDROCHLORIDE	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	200MG/10ML (20MG/ML)	No	No	1998/03/19	1998/03/19	DR REDDYS	Discontinued
NALBUPHINE HYDROCHLORIDE	207595	001	ANDA	NALBUPHINE HYDROCHLORIDE	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	10MG/ML (10MG/ML)	No	No	2019/01/11	2019/01/11	RISING	Discontinued
NALBUPHINE HYDROCHLORIDE	207595	002	ANDA	NALBUPHINE HYDROCHLORIDE	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	20MG/ML (20MG/ML)	No	No	2019/01/11	2019/01/11	RISING	Discontinued
NALBUPHINE HYDROCHLORIDE	206506	001	ANDA	NALBUPHINE HYDROCHLORIDE	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	100MG/10ML (10MG/ML)	No	No	2019/02/06	2019/02/06	RISING	Discontinued
NALBUPHINE HYDROCHLORIDE	206506	002	ANDA	NALBUPHINE HYDROCHLORIDE	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	200MG/10ML (20MG/ML)	No	No	2019/02/06	2019/02/06	RISING	Discontinued
NALBUPHINE HYDROCHLORIDE	216049	001	ANDA	NALBUPHINE HYDROCHLORIDE	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	100MG/10ML (10MG/ML)	No	No	2024/09/19	2024/09/19	SOMERSET THERAPS LLC	Prescription
NALBUPHINE HYDROCHLORIDE	216049	002	ANDA	NALBUPHINE HYDROCHLORIDE	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	200MG/10ML (20MG/ML)	No	No	2024/09/19	2024/09/19	SOMERSET THERAPS LLC	Prescription
NALBUPHINE HYDROCHLORIDE	216050	001	ANDA	NALBUPHINE HYDROCHLORIDE	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	10MG/ML (10MG/ML)	No	No	2024/09/19	2024/09/19	SOMERSET THERAPS LLC	Prescription
NALBUPHINE HYDROCHLORIDE	216050	002	ANDA	NALBUPHINE HYDROCHLORIDE	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	20MG/ML (20MG/ML)	No	No	2024/09/19	2024/09/19	SOMERSET THERAPS LLC	Prescription